The first batch of nanoparticles for the anti-nicotine vaccine was synthesized in Khimki
Selecta (RUS), the Russian division of the Rusnano portfolio company Selecta Biosciences, Inc., synthesized the first batch of tSVP nanoparticles with an active component of an anti-nicotine vaccine.
14.03.2013